We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

QIAGEN

Qiagen is a provider of sample and assay technologies for molecular diagnostics and applied testing, including comple... read more Featured Products: More products

Download Mobile App




Saliva-Based Assay Developed for HPV-Driven Oropharyngeal Cancer

By LabMedica International staff writers
Posted on 04 Jun 2020
The incidence of high-risk human papillomavirus (HR-HPV−16, −18, −33) driven oropharyngeal cancer (OPC) is rapidly increasing in developed countries. More...
HPV-driven OPCs have surpassed cervical cancer as the most common HPV-driven cancer in the USA.

Oropharyngeal cancer caused by human papillomavirus (HPV) is a rising global concern. Early lesions are small and are often located in difficult to access areas (such as the crypts of the tonsils or base of tongue). Unlike cervical cancer, there is no standard or routine screening program for HPV-driven OPC.

Biomedical Scientists at the Queensland University of Technology (Brisbane, Australia) and their colleagues recruited 650 cancer-free healthy individuals with sufficient amount of DNA were tested for oral HPV-16 DNA. All were from the Queensland Region, Australia and studied between May 2016 and October 2017. Of these three have been identified to have persistent oral HPV-16 DNA infection.

From a single individual salivary oral rinse samples were collected at baseline, 6, 12, 36 month, and 2 weeks after his bilateral tonsillectomy. Total DNA was extracted from salivary oral rinse and tonsillar tissue samples using the QIAmp DNA Mini Kit (Qiagen, Germantown, MD, USA). For detection of HPV-16 genotyping, the qPCR assay targeting the opening reading frame (ORF) region of HPV16 E6/7 was carried out with the QuantStudio 7 Flex Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). The team also performed immunochemistry, DNA genotyping and viral load studies and histology.

The team observed that the HPV-16 biomarker fell to undetectable levels in saliva after surgeons removed cancerous tumors from a high-risk study participant that they had been tracking for three years. Although the report does not provide enough evidence that the test can be used as a screening tool, it demonstrates that a screened individual can receive significantly less morbid treatment than would be required for the standard presentation at a more advanced stage. The pattern of salivary HPV-DNA detection in this case demonstrated an exponential upward trend with the titer at first sample being 3.43 copies per 50 ng and the final titer before surgery of 1281.7 viral copies per 50 ng.

The authors concluded that their report support the value of a salivary oral rinse test as a potential screening tool. Unlike previously published work, the study is the first to demonstrate that continuous monitoring of HPV-16 DNA in salivary oral rinse samples can detect occult OPC. The study was published originally March 31, 2020 in the journal Frontiers in Oncology.





New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automatic Hematology Analyzer
LABAS F9000
New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.